Both in Surgical Instruments
InspireMD vs Nephros
Over the past year NSPR returned −71.3% and NEPH returned −39.7%; their daily moves had a correlation of 0.11.
NSPR −71.3% NEPH −39.7%Growth of $1, one year, split-adjusted
| Metric | NSPR | NEPH |
|---|---|---|
| Price | $0.6579 | $3.24 |
| Market cap | $30.8M | $35.2M |
| Today | +22.06% | 0.00% |
| 1 month | +13.4% | −8.7% |
| 6 months | −40.2% | +3.2% |
| Year to date | −63.0% | −33.6% |
| 1 year | −70.2% | −43.2% |
| Revenue growth (YoY) | −0.4% | +36.2% |
| Gross margin | −43.7% | 66.9% |
| Net margin | −808.8% | 19.9% |
| P/E (TTM) | — | 20.3× |
| Price / sales | 2.8× | 1.7× |
| Net cash | $30.4M | $4.7M |
| Dividend yield | — | — |
| Volatility (60d) | 90.0% | 72.6% |
| Short % of float | 0.2% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).